2017
DOI: 10.14712/18059694.2018.13
|View full text |Cite
|
Sign up to set email alerts
|

Severe Self-Inflicted Acute Ocular Siderosis Caused by an Iron Tablet in the Conjunctival Fornix

Abstract: We present the case of a female patient who grinded a ferrous sulfate tablet and placed it at the conjunctival fornix of her left eye. She rapidly developed severe ocular siderosis, with profoundly decreased visual acuity, corneal opacities, cataract, retinal degeneration and ultimately phthisis bulbi. To our knowledge, this is the first report on the consequences of application of an iron tablet on the conjunctiva.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 4 publications
(9 reference statements)
0
6
0
Order By: Relevance
“…It can present as a cataract in the lenses, glaucoma, iris heterochromia, mydriasis, and retinitis pigmentosa changes. On electroretinogram, the changes of ocular siderosis are an increase in “a” waves followed by a continual reduction of “b” waves [ 1 4 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…It can present as a cataract in the lenses, glaucoma, iris heterochromia, mydriasis, and retinitis pigmentosa changes. On electroretinogram, the changes of ocular siderosis are an increase in “a” waves followed by a continual reduction of “b” waves [ 1 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…With the availability of advanced vitrectomy techniques, early removal of IOFBs is the preferred treatment modality. Early removal prevents vision-threatening complications like endophthalmitis and siderosis [ 1 4 ]. Also, it is important to note that potential complications of the removal procedures still pose a challenge.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Wise et al reported that deferoxamine subconjunctival injection (10–100 mg) was able to prevent the development of OS but not to resolve established cases because chelation can only remove free iron ions before becoming stored within cells [ 119 ]. Additionally, topical deferoxamine drops (concentration 10%) showed no clinical improvement [ 121 ]. It is crucial to remark that deferoxamine-related toxicity exists, both systemic (bone dysplasia and high-frequency sensorineural hearing impairment) and topic (RPE alteration, reduction in ERG amplitudes, nyctalopia and colour vision alteration, principally in the tritan axis) [ 122 ].…”
Section: Treatmentmentioning
confidence: 99%